Market Research Logo

Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing: Industry Analysis & Outlook (2016-2020)

Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing: Industry Analysis & Outlook (2016-2020)

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In vitro diagnostics (IVD) are the medical tests which are intended to perform diagnoses from sample of body fluids in a controlled environment outside a living organism. In vitro diagnostic (IVD) tests are performed to conduct diagnoses from assays in a test tube, or in a controlled environment outside a living organism.

Molecular Diagnostics is a technology used in the process of in vitro diagnosis. Molecular diagnostics involves the measurement of DNA, RNA, proteins or metabolites in order to detect genotypes, mutations or biochemical changes in the body. Molecular diagnostics market is escalating beyond the identification of infections. It is becoming an essential part of disease management and therapy. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine. The market is further expected to see a robust growth with increased research and development.

The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious diseases like Ebola and swine flu, they would require accurate diagnostics, which will instigate the growth of the molecular diagnostics technology in the future, thereby posing tremendous growth potential for the market. Asia-Pacific is expected to register the highest growth rate in expansion of molecular diagnostics in the coming years.

The key factors driving growth of the MD market includes fast approvals for companion diagnostics reagents, increase in emergence of infectious disease, innovation and technical development, rising ageing population, and escalating global healthcare expenditure. However, there are certain factors hindering the growth of the market like high initial cost, obligation of skilled labor, and lack of proper healthcare infrastructure. The major trends featuring the market includes increasing clinical microbiological laboratories in developing nations, next generation sequencing, and increase in sale of point of care devices.

The report offers an in-depth analysis of the Global Molecular Diagnostics Market with focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing. It covers the regional and global aspect of the market. Competition is concentrated in the hands of few major companies, of which Roche Holding, Abbott Laboratories, Hologic Inc., and Qiagen have been covered in the report.


1. Market Overview
1.1 Diagnostics
Table 1: IVD Market – Segments by Technology
1.2 Molecular Diagnostics
Table 2: Molecular Diagnostics – Traditional Process
Table 3: Molecular Diagnostics Breakdown
1.3 Purpose of Molecular Diagnostics
Table 4: Main Purposes of Molecular Diagnostics
2. Global In Vitro Diagnostics (IVD) Market
2.1 Global IVD Market by Value
Table 5: Global IVD Market by Value (2011-2015)
2.2 Global IVD Market Forecast by Value
Table 6: Global IVD Market Forecast by Value (2016-2020)
2.3 Global IVD Market by Segment
Table 7: Global IVD Market by Segment (2015)
2.4 Global IVD Market by Technology
Table 8: Global IVD Market CAGR by Technology (2013-2017)
3. Global Molecular Diagnostics (MD) Market
3.1 Global MD Market by Value
Table 9: Global Molecular Diagnostics (MD) Market by Value (2011-2015)
3.2 Global MD Market Forecast by Value
Table 10: Global MD Market Forecast by Value (2016-2020)
3.3 Global MD Market by Application
Table 11: Global MD Market by Application (2015)
3.4 Global MD Market Forecast by Region
Table 12: Global MD Market Forecast by Region (2019)
3.5 Global MD Market by Test Type
3.5.1 Global HPV Market by Value & Volume
Table 13: Global HPV Market by Value & Volume (2011-2015)
3.5.2 Global HPV Market Forecast by Value & Volume
Table 14: Global HPV Market Forecast by Value & Volume (2016-2020)
3.5.3 Global CT/NG Market by Value & Volume
Table 15: Global CT/NG Market by Value & Volume (2011-2015)
3.5.4 Global CT/NG Market Forecast by Value & Volume
Table 16: Global CT/NG Market Forecast by Value & Volume (2016-2020)
3.5.5 Global Genetic Testing Market by Value
Table 17: Global Genetic Testing Market by Value (2011-2015)
3.5.6 Global Genetics Testing Market Forecast by Value
Table 18: Global Genetic Testing Market Forecast by Value (2016-2020)
4. Regional Markets
4.1 North America
4.1.1 North America MD Market by Value
Table 19: North American MD Market by Value (2011-2015)
4.1.2 North America MD Market Forecast by Value
Table 20: North American MD Market Forecast by Value (2016-2020)
4.1.3 North America MD Market by Application
Table 21: North American MD Market by Application (2015)
4.2 Europe
4.2.1 European MD Market by Value
Table 22: European MD Market by Value (2011-2015)
4.2.2 European MD Market Forecast by Value
Table 23: European MD Market Forecast by Value (2016-2020)
4.2.3 European MD Market by Application
Table 24: European MD Market by Application (2015)
4.3 Korea
4.3.1 Korean MD Market by Value
Table 25: Korean MD Market by Value (2011-2015)
4.3.2 Korean MD Market Forecast by Value
Table 26: Korean MD Market Forecast by Value (2016-2020)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Fast Approvals for Companion Diagnostics Reagents
Table A: The US approvals for CD Reagents
5.1.2 Rising Emergence of Infectious Disease
Table B: Growing Cases and Prevalence of STDs in the US (2008-2015)
5.1.3 Rise in Medical Check-up Participation Rate
Table C: Participation Rate in Medical Checkups (2010-2015)
5.1.4 Innovation and Technical Development
5.1.5 Clear Guidance by FDA
5.1.6 Rise in Global Ageing Population
Table 27: Worldwide Ageing Population 60 Years or Older (2000-2030E)
5.1.7 Rising Global Healthcare Expenditure
Table 28: Rising Global Health Care Expenditure (2010-2015)
5.2 Key Trends and Developments
5.2.1 Increasing Clinical Microbiology Laboratories in Developing Nation
5.2.2 Next Generation Sequencing
5.2.3 Targeting Anti-Biotic Resistance
5.2.4 Growth in Point of Care Diagnostics
Table 29: Global POCT Device Sales (2012-2017E)
5.2.5 Booming Medical Device Industry
Table D: Global Medical Equipment/Devices Sales (2015/2020)
5.3 Challenges
5.3.1 High Initial Cost
5.3.2 Obligation of Skilled Labour
5.3.3 Urgent need for Proper Infrastructure
6. Competitive Landscape
6.1 Global IVD Market
6.1.1 Market Share Comparison
Table 30: Global IVD Market Share (2015)
6.2 Global MD Market
6.2.1 Market Share Comparison
Table 31: Global MD Market Share (2015)
6.2.2 Market Cap Comparison
Table 32: Global MD Market Cap. Comparison (2015)
6.2.3 Competitive Position by Segment
Table E: Global MD Market by Segment Competitiveness (2015)
7. Company Profiles
7.1 Roche Holding
7.1.1 Business Overview
Table 33: Roche’s Revenue by Business Segments (2015)
7.1.2 Financial Overview
Table 34: Roche’s Revenue and Net Income (2011-2015)
7.1.3 Business Strategy
7.2 Abbott Laboratories
7.2.1 Business Overview
Table 35: Abbott Laboratories' Revenue Share by Segment (2015)
7.2.2 Financial Overview
Table 36: Abbott Laboratories' Revenue and Net Income (2011-2015)
7.2.3 Business Strategy
7.3 Hologic Inc.
7.3.1 Business Overview
Table 37: Hologic’s Revenue by Business Segments (2015)
7.3.2 Financial Overview
Table 38: Hologic’s Revenue and Net Income (2015)
7.3.3 Business Strategy
7.4 Qiagen
7.4.1 Business Overview
Table 39: Qiagen’s Revenue by Business Segments (2015)
Table 40: Qiagen’s Revenue by Geographic Region (2015)
7.4.2 Financial Overview
Table 41: Qiagens Revenue and Net Income (2011-2015)
7.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report